Adynxx, Inc.   Report issue

For profit Phase 2
Founded: San Francisco CA United States (2007)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2013
NCT01731730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Adynxx, Inc.